Reconstituting factor concentrates: Defining Evidence of Coaching Non-Experts (DEVICE) in haemophilia--a prospective randomized feasibility study.
The introduction of new needleless devices as demanded by the US Department of Labor Occupational Safety and Health Administration (OSHA) has caused problems with the reconstitution of antihaemophilic factor in emergency situations. Our aim therefore was to evaluate the feasibility of a needleless device for reconstitution of antihaemophilic factor for non-haemophilia experts and to define evidence of the need for coaching these physicians via providing two additional photographs illustrating the two key points of the factor reconstitution process. Twenty-eight physicians of a tertiary care university children's hospital were randomized into two groups, either with no further explanation of the reconstitution device or with two additional photographs, showing the two key steps of the procedure. Reconstitution of dummy-factor concentrate was video-taped and evaluated by a blinded helper. Main outcome measure was the successful reconstitution of dummy-factor concentrate and procedure failure respectively. Of the group without explanation of the reconstitution device, only two of 14 physicians were able to reconstitute the dummy-factor concentrate. Of the group receiving two photographs, nine of 14 completed the task successfully (P = 0.0068). The needleless device is not self explaining to non-haemophilia physicians involved in emergency services. Coaching via short to the point instructions as provided by simple visual educational material therefore is crucial to enable these physicians to resolve the expensive emergency drug quickly and correctly. Companies concerned with the production of any devices to dissolve drugs, especially for treatment of rare diseases as haemophilia, therefore should take measures to simplify therapy.
Bidlingmaier
C
C
Paediatric Haemophilia Centre, Dr. v. Haunersches Kinderspital, Ludwig Maximilians University, Lindwurmstrasse 4, 80337 Munich, Germany.
Kurnik
K
K
Hölscher
G
G
Kappler
M
M
D002648:Child; D003029:Coagulants / Q000008:administration & dosage*; D004333:Drug Administration Routes; D004502:Education, Medical, Continuing; D004635:Emergency Medicine / Q000193:education*; D004864:Equipment and Supplies / Q000592:standards; D005169:Factor VIII / Q000008:administration & dosage*; D005240:Feasibility Studies; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D008505:Medical Staff, Hospital / Q000193:education*; D011446:Prospective Studies
D003029:Coagulants; D005169:Factor VIII